Senti Biosciences, Inc. (SNTI)
(Delayed Data from NSDQ)
$1.74 USD
+0.06 (3.57%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $1.75 +0.01 (0.57%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Senti Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SNTI 1.74 +0.06(3.57%)
Will SNTI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SNTI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNTI
SNTI Stock Skyrockets on Initial Data From Phase I Cancer Study
SNTI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SNTI
Senti Bio's Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. ...
SNTI Appoints Bryan Baum to Board of Directors | SNTI Stock News
Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors | ...
Senti Bio appoints Bryan Baum to board of directors